Introduction
============

The adaptive immune system ensures the survival of humans and other vertebrates in the face of rapidly evolving and genetically diverse infectious diseases. B lymphocytes are an essential component of this system and express receptors on their cell surface (B-cell receptors; BCRs) capable of specifically binding foreign antigens. BCRs are membrane-bound immunoglobulins composed of two large heavy chain molecules and two smaller light chain molecules, encoded in humans by the genes *IGH* and *IGL* (or *IGK*), respectively. The diversity of BCRs expressed by an individual's B cells is vast, and comprises both naive receptors that are randomly generated from the germline during development, as well as receptors that are retained after successfully binding antigen during previous infections. Populations of BCRs can rapidly improve antigen binding during infection through an evolutionary process of mutation and selection known as affinity maturation ([@msw015-B46]). Because BCR sequences are diverse and diverge rapidly, concepts from molecular evolution should be beneficial in understanding the dynamics of the adaptive immune system within individuals. T-cell receptors (TCRs) are a second class of immune receptors that can bind foreign antigen. Although diverse TCRs are also generated randomly from germline gene sequences, and their comparison with BCRs can be illuminating, TCRs do not undergo affinity maturation nor exhibit rapid evolution during infection. Therefore in this review, we focus solely on BCR biology.

Apart from molecular assays that characterize sequence length polymorphisms (e.g., TCR immunoscope assays; see [@msw015-B5]) there was, until recently, a paucity of data on within-individual BCR sequence diversity for researchers to explore. That situation has now changed with the application of next-generation sequencing to BCRs ([@msw015-B6]; [@msw015-B68]). With this technique, researchers can directly observe the somatic genetic changes that generate the diversity of the BCR repertoire, providing an unprecedented picture of the adaptive immune system as an evolving population of cells. Analyses of these data from an evolutionary perspective have led to insights into the aging of the B-cell repertoire ([@msw015-B82]) and into the process of affinity maturation ([@msw015-B16]; [@msw015-B87]), and have many applications across a broad range of diseases (see [table 1](#msw015-T1){ref-type="table"}). Table 1**.** Applications of BCR Repertoire Sequencing.ApplicationDiseases/InfectionsSignificanceChallengesIdentification of broadly neutralizing antibodies (BNAbs)Infection with rapidly evolving pathogens such as HIV, Hepatitis C virus, influenza virusesPotential for use as vaccine targets ([@msw015-B29])Provide model system for understanding affinity maturation, coevolution, and immune development (e.g., [@msw015-B85])Lineages are often large and diverse, often with high levels of hypermutation, long CDR3s, and poly reactivity ([@msw015-B29])Study of vaccine responsesAny disease for which vaccines are used or being developed, e.g., Influenza, typhoid, or EbolaA model system for immune response with a known stimulus ([@msw015-B24])Identifying correlates of immune protection following vaccinationDistinguishing vaccine-specific changes to the BCR repertoire from healthy repertoire diversityVariable immune responses among individuals to the same stimulus ([@msw015-B1]; [@msw015-B35])Tracking B-cell migration and development within the bodyAutoimmune diseases such as multiple sclerosis; cancersIdentifies migration of B cells between tissue compartments ([@msw015-B81])Can identify the sites at which B cells mature ([@msw015-B72])Accurate B-cell lineage assignmentModeling potentially complex migration patternsDifferential sampling between tissuesDisease diagnosisAutoimmune diseases such as multiple sclerosis and rheumatoid arthritis; cancers, in particular B-cell lymphomaA direct and potentially cheap diagnosis toolImproved understanding of diseaseProvide clinical markers of disease progression ([@msw015-B62])Complex and multiple disease epitopes induce complex responsesLow level presence of B cells associated with disease

Despite these advances, there are important challenges in applying models and methods from molecular evolution to BCR sequences, which stem both from the complex biology of B cells and the nature of available data. Unlike most natural populations, naïve BCR sequences do not descend from a single common ancestor through a process of point mutation, but are instead generated from a diverse set of germline gene segments through a process of somatic recombination (see below). In addition, the mutation process during affinity maturation is strongly dependent on the sequence context of flanking nucleotides ([@msw015-B90]) and selection on the resulting amino acid sequence is complex and site-specific, driven by the need to avoid dangerous self-reactivity while concurrently enhancing pathogen binding. Finally, BCRs are a complex of heavy and light chain immunoglobulin molecules, and information from both is necessary for a complete understanding of BCR evolution and function. Here, we review the current literature on these topics and explore how molecular evolution and phylogenetics may contribute to future BCR research.

B-Cell Development
==================

The initial diversity of the BCR repertoire is the result of a somatic recombination process called V(D)J recombination. This process brings together one each of the variable (V), diversity (D), and joining (J) segments of the *IGH* locus on chromosome 14 to form an exon in the heavy chain immunoglobulin gene, and one each of the V and J segments of the *IGL* (or *IGK*) locus to form the light chain. Not all gene segments are utilized. Of the 123--129 *IGHV* gene segments, 44 contain open reading frames (ORFs); further, 25 of the 27 D segments and 6 of the 9 J segments have been shown to be used for somatic recombination in the heavy chain ([@msw015-B41]; [@msw015-B44]). During this process, additional sequence diversity is generated by random deletion or insertion of nucleotides at segment junctions. This process combines highly variable sequence regions that determine antigen binding (the complementarity determining regions; CDRs) with more conserved framework regions (FWRs) that provide structural support. Thus each naïve B cell has its own BCR sequence, and the number of possible BCR sequences is huge, with models predicting at least 10^18^ ([@msw015-B16]), far greater than the number of B cells in the body. The process may generate nonproductive (e.g., out-of-frame) coding sequences; when this happens, the B cell may recombine its second copy of the *IGH* gene. If this too fails to produce a viable recombinant sequence then the cell undergoes apoptosis, which further modulates the background genetic diversity of receptors ([fig. 1](#msw015-F1){ref-type="fig"}). The surviving, naïve B cells then undergo an initial round of selection for lack of self-reactivity, before they are released from the bone marrow into peripheral blood ([@msw015-B53]). F[ig]{.smallcaps}. 1Chord diagrams showing the pairing of V and J segments within (*a*) productive and (*b*) nonproductive IgM sequences from a single healthy individual. Chord widths represent the proportion of sequences with a given V (colored) and J (gray) segment pairing. The five most common V segments in productive rearrangements (and all J segments) are labelled. Note that *IGHV3-23/IGHJ4* was significantly more common in productive versus nonproductive rearrangements, which may indicate functional bias of that pairing. The figure was generated from data in [@msw015-B16], which was aligned to the IMGT reference ([@msw015-B40]) using IgBLAST ([@msw015-B92]). Productive rearrangements were subsampled to the same read depth as nonproductive rearrangements (∼2 × 10^5^ reads); the values displayed in (*a*) are means of 100 subsampling repetitions.

Once a naïve B cell is activated by binding a foreign antigen, it undergoes cell division (clonal expansion) and initiates processes that somatically alter the BCR sequence and diversify the clonal population. In parallel, a mechanism called class switching alters the constant region of the heavy chain, changing the type and function of the BCR and its interaction with other molecules; although this does not affect its antigen-binding properties, it does leave a molecular mark that can be used to separate naïve BCRs from those that have undergone affinity maturation. Affinity maturation modifies antigen binding through a process of random and rapid sequence change, termed somatic hypermutation (SHM), and by selection. SHM involves greatly increased mutation rates of approximately 10^−3^ changes per nucleotide per cell division, corresponding to approximately one mutation per cell division in the relevant locus ([@msw015-B75]; [@msw015-B79]). Mechanistically, these mutations are induced by the enzyme activation-induced cytodine deanimase (AID), which deaminates cytosine to uracil during transcription ([@msw015-B52]; [@msw015-B75]; [@msw015-B58]). Importantly, for evolutionary analysis, SHM is a random and strongly nonuniform process, and clearly distinct from the processes of germline mutation and evolution. In particular, SHM is context-dependent such that the probability of mutation at a site is strongly influenced by neighboring nucleotides ([@msw015-B67]; [@msw015-B90]; [@msw015-B16]). The resulting mutations are further shaped by a round of selection, in which B cells compete for survival and replication signals by competitively binding to antigens ([@msw015-B58]). The combination of these processes shapes both the type and rate of observed mutations across the *IGH* and *IGL* loci.

Sequencing the BCR Repertoire
=============================

The extraordinary variability of BCR sequences poses challenges for targeted sequencing. We provide here only a brief summary of current sequencing approaches, in particular as they relate to the analysis of BCR diversity. Rearranged VDJ segments are flanked by introns, so targeting germline DNA requires a cocktail of polymerase chain reaction (PCR) primers ([@msw015-B38]). A challenge for this approach is to control for PCR bias, which could skew the frequency of sequenced variants and obscure the signal of clonal expansion. An alternative approach that can significantly reduce the problem of PCR bias is to target expressed mRNA, in which case the constant regions flanking the VDJ segments in mature mRNA can be used for PCR priming ([@msw015-B23]). In addition, different classes of B cells can be distinguished by targeting different constant regions. The challenges for mRNA sequencing are to 1) disentangle variation in sequence frequency that is due to differential expression, which can be extensive, from that due to clonal expansion; and 2) ensure that sequencing error and subsequent bioinformatic processing do not introduce systematic biases into subsequent evolutionary analyses. For a more detailed discussion of BCR repertoire sequencing, see the reviews by [@msw015-B4] and [@msw015-B61].

Sequencing of the somatically altered heavy chain has the potential to reveal the clonal structure and dynamics of the B-cell population through time, and this review focuses on the analysis of bulk sequence data from this region. However, although the majority of variation in BCR sequences is concentrated in the heavy chain, and in particular the CDRs ([@msw015-B86]; [@msw015-B25]), the light chain also contains mutations that may affect antigen binding. If one's goal is to characterize entire antibodies, or to understand the binding properties of a given heavy chain sequence, then knowledge of paired heavy and light chain sequences is required. Computational approaches have previously sought to infer how heavy and light chain sequences are paired from independently sequenced sets of sequences by using relative frequencies ([@msw015-B59]), or the shapes of phylogenetic trees ([@msw015-B95]) of heavy and light chain sequences. Recently, single-cell technologies have enabled natively paired heavy and light chains to be sequenced by attaching unique barcodes to cDNA from individual cells ([@msw015-B8]; [@msw015-B47]; [@msw015-B73]; [@msw015-B74]). Alternatively, oligo-dT beads that link heavy and light chains from a single cell have been used ([@msw015-B10], [@msw015-B11]).

Measuring BCR Diversity
=======================

Once BCR sequences are generated, statistical and computational approaches are necessary to explore and summarize their diversity, in order to reveal associations with immune responses or disease status, or to identify BCR sequences of specific interest. The exceptional diversity of the BCR repertoire, and its dynamic nature, makes comparative study within and among individuals challenging.

Several different measures have been proposed, and can be distinguished into those that characterize raw sequence variability versus those that depend on the frequency of BCR lineages, clones or clusters (i.e., groups of identical or similar sequences; see next section). In the context of viral infection, both the number of somatic mutations ([@msw015-B9]; [@msw015-B82]; [@msw015-B23]) and V, J gene usage ([@msw015-B94]) have proved useful. CDR3 sequence length also has been used to distinguish repertoires after pneumococcal vaccination ([@msw015-B1]; [@msw015-B9]; [@msw015-B23]). Diversity statistics such as the Gini index or mean clone size are also used to investigate BCR diversity ([@msw015-B3]; [@msw015-B23]; [@msw015-B32]). [Figure 2](#msw015-F2){ref-type="fig"} provides a graphical representation of BCR diversity under different conditions. F[ig]{.smallcaps}. 2Network diagrams that visualize the diversity and clonal structure of BCR sequences. BCR sequences were obtained from (*a*) two healthy people, (*b*) two individuals infected with HIV-1, sampled during early infection, and (*c*) two patients with chronic lymphocytic leukemia, a B-cell cancer. Each point/circle represents a unique BCR sequence, the size of which is proportional to how common that sequence is. Edges are drawn between pairs of sequences that differ by exactly one nucleotide change. Note that samples do differ by read depth (approximately 3.4 × 10^4^ and 3.6 × 10^4^ for part \[*a*\], 9.2 × 10^4^ and 3.6 × 10^5^ for part \[*b*\], 5.1 × 10^4^ and 2.6 × 10^4^ for part \[*c*\]). Parts (*a*) and (*c*) are reproduced with permission from [@msw015-B3] and part (*b*) from [@msw015-B32].

Other approaches seek to characterize BCR diversity using statistical models. [@msw015-B51] introduced a maximum entropy model that characterizes the repertoire as a statistical distribution, whereas [@msw015-B16] used probabilistic inference to quantify the process of VDJ recombination and SHM. [@msw015-B27] proposed employing entropy measures developed in ecology research, which unify a range of diversity measures into a single profile.

A common assumption of these approaches is that clonal expansions observed in infected individuals correspond to B-cell responses against the pathogen under study. This may not always be true, especially in instances of coinfection with multiple pathogens. Further, some infections may manipulate host immune responses through so-called superantigens (e.g., staphylococcal protein A), which trigger large, nonspecific clonal expansions that disrupt antigen-specific affinity maturation ([@msw015-B76]). Such phenomena do not in general prevent clonal expansions from being useful indicators of immune dynamics, but require them to be carefully interpreted in the context of the particular host--pathogen system.

Comparison of BCR populations among individuals is of interest because repertoires may become similar if individuals are exposed to the same pathogen, giving rise to a shared, "public" repertoire. Differences in BCR repertoires between individuals are likely generated by many factors including age ([@msw015-B82]), germline genetics ([@msw015-B82]), and infection history ([@msw015-B63]; [@msw015-B83]). Infectious diseases typically present many epitopes, and even when different B cells target the same epitope, it is possible for the different BCR sequences to bind equally effectively. Despite these complexities, BCR convergence following identical stimuli has been observed, and has enabled the identification of antibodies reactive against influenza vaccines ([@msw015-B34]; [@msw015-B49]; [@msw015-B77]) and dengue virus vaccines ([@msw015-B55]). In addition, antibodies against HIV that exhibit the same broadly neutralizing phenotype, and which share some common sequence elements, have evolved independently in different patients ([@msw015-B64]; [@msw015-B94]). It is currently an open question whether convergent molecular evolution of BCR sequences is a common or an exceptional phenomenon ([@msw015-B88]). Some tests of convergence have been developed in other contexts, such as [@msw015-B93] convergent evolution hypothesis test, which directly compares substitution models of convergent versus independent evolution along preselected lineages. This and other methods designed to detect convergence (e.g., [@msw015-B57]) may improve our understanding.

Clonal Lineage Assignment and Clustering
========================================

Molecular phylogenetics is an undeniably powerful tool for analysis of sequence diversity. However, its application to BCR repertoires is impeded by the V(D)J recombination process, the existence of which means that not all BCR sequence differences are due to point mutation through descent from a common ancestor. Consequently, sequences must be grouped by lineage, each representing sequences that descend from a single ancestral B cell, before they can be analyzed phylogenetically ([@msw015-B30]).

A key step in this process is the alignment of BCR sequences to reference data sets of V, D, and J gene segments, in order to determine their germline origin. Several such alignment methods are available: IMGT/High-V-Quest ([@msw015-B2]) is popular and provides a well-curated reference data set; IgBLAST ([@msw015-B92]) can be run with a user-specified reference data set, and IgSCUEAL uses phylogenetic relationships between germline genes to increase the accuracy of assignment ([@msw015-B18]). Other tools include iHMM-Align ([@msw015-B22]) that implements a hidden Markov model, and VBASE2 ([@msw015-B60]) that uses a reference data set provided by Ensembl. Other techniques, using methods adopted from phylogenetic ancestral state reconstruction, assign V(D)J segments while also quantifying uncertainty in assignment ([@msw015-B36]). However, germline V, D, and J segments vary considerably among individuals and new alleles are still being discovered, so the reference data set may be inaccurate ([@msw015-B21]). Segment similarity, junctional diversity, SHM, and sequencing errors all further increase the difficulty of unambiguously assigning BCR sequences to specific germline segments. This is particularly true for D segments, due to their short length (11--37 nucleotides; [@msw015-B41]; [@msw015-B26]) and the frequent occurrence of deletions during V(D)J recombination, which may remove part or all of a D segment ([@msw015-B16]).

Several studies sidestep the problem of germline assignment, and instead use clustering approaches to group similar BCR sequences by using either the entire V(D)J region sequence ([fig. 2](#msw015-F2){ref-type="fig"}; [@msw015-B3]; [@msw015-B32]) or the CDR3 region ([@msw015-B35]; [@msw015-B70]; [@msw015-B39]). A threshold number of differences (edit-distance) is often used to determine whether sequences belong to the same or different clusters. One difficulty with this approach is the choice of threshold. Some studies address this by exploring multiple thresholds; edit-distances of three to five differences have been chosen by looking at how cluster numbers and sizes change as the threshold is increased ([@msw015-B90]; [@msw015-B39]). However, a more principled approach is clearly needed to test how closely these clustering techniques reconstruct the true clonal structure of the B-cell population. At present they appear well suited for the detailed analysis of recently diverged clones ([@msw015-B39]), and for quantifying the diversity of the BCR repertoire in general ([@msw015-B3]; [@msw015-B32]; [@msw015-B77]). However, it is unlikely that clustering approaches based on edit-distances will be effective in accurately identifying large, diverse lineages. For example, broadly neutralizing HIV lineages often show high levels of genetic diversity ([fig. 3](#msw015-F3){ref-type="fig"}; [@msw015-B85]), and the intermediate (i.e., ancestral) sequences necessary for accurate clustering may not be available in many cases, because affinity maturation occurs in the germinal centers rather than in peripheral blood ([@msw015-B56]). Studies that have successfully isolated large and diverse B-cell lineages from HIV-infected patients have generally done so using by combining sequence analysis with detailed experimental work ([@msw015-B94]). F[ig]{.smallcaps}. 3Maximum-likelihood phylogenetic tree of the VRC01 BNAb lineage sampled at ten time points over 15 years of diversification within a single individual infected with HIV-1. Each tip represents a BCR heavy chain sequence; terminal branches are colored by time point of sampling (see key). The red circle at the root represents the germline sequence (IGHV1-2\*02 and IGHJ1\*01, D region left unassigned). Note the general, but not complete, trend of increasing genetic divergence from the root with sampling time. Late-sampled sequences near the root indicate very high rate heterogeneity among lineages; these sequences might represent inactive memory B cells. BNAb sequences were obtained through cell sorting ([@msw015-B84]) followed by high-throughput sequencing data to identify related BCRs ([@msw015-B94]). See [@msw015-B85] for full experimental details. Sequences for this tree were obtained from GenBank ([@msw015-B85]) and aligned using MUSCLE ([@msw015-B15]). A maximum-likelihood phylogeny was estimated using the GTRGAMMA substitution model in RAxML ([@msw015-B71]), and rerooted to position the germline sequence at the root with a divergence of zero. Scale bar represents genetic distance (expected changes per nucleotide site).

Untangling Mutation and Selection
=================================

The enzyme-driven nature of SHM poses a challenge for studying the molecular evolution of BCRs. Standard nucleotide substitution models typically assume that sites (either nucleotides or codons) evolve independently ([@msw015-B17]). However, SHM is strongly context dependent, to the extent that observed mutation rates vary more than 10-fold across sites (see [fig. 4](#msw015-F4){ref-type="fig"}) ([@msw015-B16]). Consequently, traditional methods for identifying positive and negative selection that rely on uniform-rate independent-site models can generate false positives when applied to BCR sequences, for example, within nonproductive (out-of-frame) sequences that are not subject to selection ([@msw015-B14]). F[ig]{.smallcaps}. 4Observed mutation (sequence difference from germline) frequency among productive heavy chain immunoglobulin sequences across the V-gene sequence (horizontal axis, IMGT unique numbering). The distribution of mutations across the region is strongly nonuniform, with mutations more likely to occur at certain positions. The CDR2 region (middle shaded box) has a high rate of observed mutations and is thought to be more important in antigen binding than the surrounding framework regions (FWR2 and FWR3). This figure was generated from the same data set as figure 1.

Models of SHM based on empirical data have been developed and include di-, tri-, penta-, and hepta-nucleotide models ([@msw015-B69]; [@msw015-B66], [@msw015-B67]; [@msw015-B90]; [@msw015-B16]), and have been used to investigate selection on the naïve B-cell repertoire ([@msw015-B16]). Selection has been explored using the "focused" binomial test, which determines whether the observed number of replacement mutations is significantly different from that expected under a null model of biased mutation but no selection ([@msw015-B31]). This framework has subsequently been extended using Bayesian inference (BASELINe; [@msw015-B89]). In common with other components of the acquired immune system (e.g., class I and II *MHC* glycoproteins; [@msw015-B91]; [@msw015-B19]), analyses indicate that BCR sequences are a mosaic of regions under a mixture of positive and purifying selection (i.e., CDRs) and structural regions whose evolution is highly constrained by purifying selection (i.e., FWRs) ([@msw015-B89], [@msw015-B87]; [@msw015-B50]).

It should also be possible to detect the action of antigen-driven selection from the shape of BCR lineage phylogenies, which represent the common ancestry of a sample of sequences from a lineage of clonally related B cells ([@msw015-B13]). Computer simulation of lineage trees generated by affinity maturation under a variety of scenarios found seven measures of tree shape that correlated strongly with immunological parameters ([@msw015-B65]). However, recent analyses using these measures concluded that they are affected by experimental factors that are difficult to control, such as the number of sequences sampled from a lineage and the number of cell divisions since initial VDJ rearrangement ([@msw015-B78]). Utilizing lineage information, such as excluding terminal branch mutations, has been shown to increase the sensitivity of methods based on the expected number of replacement mutations ([@msw015-B78]). It is interesting to note that very similar approaches were developed independently in viral phylogenetics, specifically in studies of HIV-1 and influenza populations under strong positive selection (e.g., [@msw015-B7]; [@msw015-B42]).

Recently, two further approaches to analyzing B-cell selection have been developed. [@msw015-B37] used a statistical model of selection and an empirical model of sequence mutability to study their interplay along the BCR sequences of an antibody lineage. Alternatively, one can adjust and control for the motif-targeted nature of SHM by studying and comparing productive and nonproductive BCR rearrangements within a given data set (see "B-Cell Development"; [@msw015-B38]; [@msw015-B16]; [@msw015-B50]). [@msw015-B50] combined this information with a statistical model of trait evolution ([@msw015-B43]) in order to derive a per-residue map of natural selection along the BCR.

Although antigen-driven positive selection is of great interest, of equal importance to the evolution of antigen-specific BCR sequences is the influence of purifying selection, which results from the removal of self-reactive and nonproductive receptors and which partly precedes the affinity maturation stage (see B-Cell Development). This initial selection can be studied by comparing the mutation profiles of nonproductive and productive BCR sequences; the latter often have shorter CDR3 sequences postselection, and exhibit complex and position-dependent selection for and against particular amino acids ([@msw015-B16]).

BCR Phylogenetics
=================

The process of affinity maturation generates rapid sequence evolution, so it is unsurprising that phylogenetic approaches are now routinely used to visualize how B-cell lineages undergo diversification and divergence in response to an antigen. Phylogenies have been used to address important problems, such as reconstructing ancestral BCR sequences within a lineage ([@msw015-B36]; [@msw015-B70]), detecting and measuring selection on B-cell populations ([@msw015-B78]), and studying how broadly neutralizing antibodies sometimes evolve in response to HIV infection ([@msw015-B85]). Further integration of phylogenetic concepts, including those from fields such as viral phylodynamics ([@msw015-B28]; [@msw015-B80]), may improve our understanding of affinity maturation dynamics during infection. For example, the rate of SHM evolution in a lineage over time (and its variability among lineages) could, in theory, be revealed by using molecular clock models to analyze BCR sequences sampled at different times. Further, asymmetric tree shapes might help to identify the action of strong positive selection on serially sampled antibody lineages ([fig. 3](#msw015-F3){ref-type="fig"}), analogous to phylogenetic footprint left by recurrent selection on some influenza virus lineages ([@msw015-B28]). However, as noted in the previous section, BCR lineage tree shapes may be subject to biases that are not yet fully understood ([@msw015-B78]), so for the time being they should be interpreted with caution.

Although many phylogenetic analyses focus exclusively on BCR heavy chain sequences, the light chain may also be included, for example, by concatenating the two gene sequences together ([@msw015-B85]). As both chains are inherited together during B-cell replication, they should share the same phylogenetic topology. By adding more sites to the alignment, concatenation may improve the accuracy of phylogeny estimation ([@msw015-B33]; [@msw015-B20]). However, if the mode or tempo of molecular evolution differs between heavy and light chains, then it may be advisable to divide the concatenated sequences into separate partitions, each with its own molecular clock and nucleotide substitution model (e.g., [@msw015-B54])

However, current phylogenetic models may not represent adequately the particular processes of growth and mutation that generate BCR lineages and therefore they should be applied with caution. For example, [@msw015-B85] recently used a relaxed molecular clock model to analyze the evolution of a broadly neutralizing antibody lineage (VRC01) sampled over 15 years of HIV-1 infection. The estimated date of the common ancestor of the lineage was implausibly old, which led the authors to conclude that the molecular clock model used was unrealistic. Specifically, they concluded that the mean rate of BCR evolution of VRC01 and other lineages ([@msw015-B45]; [@msw015-B12]) slowed over the course of lineage development. This work poses interesting avenues for future research, as it should be possible to test the slowdown hypothesis directly using a time-dependent molecular clock model. Alternatively, the apparent slowdown could be caused by the AID motif-driven nature of BCR mutation, in which case fundamental assumptions of the nucleotide substitution model (e.g., independence among site and time-reversibility) may be inappropriate. It is likely that current evolutionary models will need to be substantially modified or carefully selected before we can be confident in evolutionary inferences from BCR sequence data.

Conclusion
==========

BCR sequence data contain a wealth of novel immunological information and have the potential to improve our observation and understanding of the mechanisms of autoimmune disease and acquired immunity ([table 1](#msw015-T1){ref-type="table"}). However, the dynamic processes that determine the response of B-cell populations to diverse antigens differ from other forms of biological evolution in key ways, some of which are currently poorly understood. We conclude by outlining four important challenges facing the molecular evolutionary analysis of BCR sequences. **Distinguishing between biological signal and experimental error or bias.** Many aspects of experimental protocol may have an effect on observed sequence diversity, including read depth and length, PCR conditions and primers, and cell sorting. Close collaboration between experimentalists and analysts is needed to ensure that experimental choices are appropriate for subsequent evolutionary analyses.**Identifying clonally** **related cells/sequences.** For evolutionary methods to be maximally informative, it is necessary to distinguish within-individual BCR sequence differences caused by SHM from those derived from V(D)J recombination. Advances here might include improvements in sequencing or experimental protocols; development of methods to probabilistically cluster into clonal lineages; and the creation of a "gold standard" test data set allowing evaluation of methods for determining clonal lineages.**Detecting convergent evolution among B cells responding to the same stimulus.** The prevalence and importance of this process, and its utility for understanding the underlying biology of BCRs, is currently under debate. Improved understanding of the frequency distribution of naïve BCR sequences should help to estimate the fraction of the public, shared repertoire that occurs by random chance. In addition, it may be possible to adapt methods from molecular evolution and phylogenetics to make progress in this area.**Models to describe the process of BCR affinity maturation.** Although descriptive summary statistics have proven useful for the visualization and qualitative analysis of BCR repertoires, further understanding will be gained by developing stochastic process models that embody the known mechanisms of SHM and B-cell proliferation, and by the application of such models to empirical data. Finally, it is important to understand the potential biases arising from applying standard phylogenetic and molecular evolutionary models to BCR sequences. These could be investigated by analyzing artificial BCR data sets simulated under complex and biologically realistic models of sequence evolution.
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